Erika Tissino

Aviano, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12.

Journal: Blood advances
Published: October 22, 2025

Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Samples.

Evaluation of Constitutive or Induced Activation State of the VLA-4 Integrin in Human and Murine Samples.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 03, 2025

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia.

Journal: Leukemia
Published: February 13, 2025

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL.

Journal: Blood
Published: November 30, 2024

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.

Journal: HemaSphere
Published: April 26, 2024

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

Journal: Leukemia
Published: March 04, 2024

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Journal: Leukemia
Published: January 12, 2024

BCR/Integrin Interaction in CLL: A Physiologic Remnant with Clinical Relevance.

BCR/Integrin Interaction in CLL: A Physiologic Remnant with Clinical Relevance.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 23, 2023

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?

Journal: HemaSphere
Published: April 10, 2023

Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.

Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.

Journal: British journal of haematology
Published: April 04, 2023

CD49d in chronic lymphocytic leukemia: a molecule with multiple regulation layers. Comment to "Sialylation regulates migration in chronic lymphocytic leukemia".

CD49d in chronic lymphocytic leukemia: a molecule with multiple regulation layers. Comment to "Sialylation regulates migration in chronic lymphocytic leukemia".

Journal: Haematologica
Published: March 29, 2023

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Journal: Leukemia
Published: September 12, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026